Genecure Biotechnologies
Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Phase 1
- Conditions
- COVID
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2020-06-11
- Lead Sponsor
- GeneCure Biotechnologies
- Target Recruit Count
- 32
- Registration Number
- NCT04428073
Therapeutic Hepatitis C Virus Vaccine
Phase 1
- Conditions
- Chronic Hepatitis C Infection
- First Posted Date
- 2020-03-24
- Last Posted Date
- 2021-09-29
- Lead Sponsor
- GeneCure Biotechnologies
- Target Recruit Count
- 30
- Registration Number
- NCT04318379
- Locations
- 🇺🇸
Virginia Commonwealth University, Medical Center, Richmond, Virginia, United States
Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
Phase 1
- Conditions
- HIV Infections
- First Posted Date
- 2011-09-05
- Last Posted Date
- 2020-06-09
- Lead Sponsor
- GeneCure Biotechnologies
- Target Recruit Count
- 30
- Registration Number
- NCT01428596
- Locations
- 🇺🇸
University of Miami School of Medicine, AIDS Clinical Research unit, Miami, Florida, United States
News
No news found